A detailed history of Homestead Advisers Corp transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Homestead Advisers Corp holds 50,500 shares of LNTH stock, worth $4.74 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
50,500
Previous 36,200 39.5%
Holding current value
$4.74 Million
Previous $3.97 Million 13.72%
% of portfolio
0.11%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$76.22 - $116.71 $1.09 Million - $1.67 Million
14,300 Added 39.5%
50,500 $4.52 Million
Q3 2024

Nov 01, 2024

BUY
$77.7 - $123.62 $357,420 - $568,652
4,600 Added 14.56%
36,200 $3.97 Million
Q4 2023

Feb 13, 2024

BUY
$55.6 - $77.89 $1.76 Million - $2.46 Million
31,600 New
31,600 $1.96 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.45B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Homestead Advisers Corp Portfolio

Follow Homestead Advisers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

News

Stay updated on Homestead Advisers Corp with notifications on news.